Cycode Leads Code to Cloud Shift with 200% Y-o-Y Revenue Growth
August 01, 2023 09:00 ET
|
Cycode
SAN FRANCISCO, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Cycode, the leading Application Security Posture Management (ASPM) platform for code to cloud, today announced its 200% year-over-year revenue growth...
Canon Business Process Services Announces New Executive Appointments
July 05, 2023 14:41 ET
|
Canon U.S.A., Inc.
New York, NY, July 05, 2023 (GLOBE NEWSWIRE) -- Canon Business Process Services, a wholly owned subsidiary of Canon U.S.A., Inc., announces two executive appointments that took effect July 1. These...
Canon U.S.A., Inc. Announces New Executive Appointments
July 05, 2023 12:50 ET
|
Canon U.S.A., Inc.
MELVILLE, NY, July 05, 2023 (GLOBE NEWSWIRE) -- Canon U.S.A., Inc., a leader in digital imaging solutions, is proud to announce executive appointments and promotions that took effect July 1. These...
Angus Gold Strengthens its Board and Management Team
June 28, 2023 07:30 ET
|
Angus Gold Inc.
Highlights: David Palmer appointed as Chairman and Director of the CompanyBreanne Beh appointed President and CEO, effective July 10, 2023Appointments are part of the Company’s initiative to build...
VEON Appoints Omiyinka Doris Group General Counsel
June 16, 2023 04:34 ET
|
VEON Ltd.
VEON Appoints Omiyinka Doris Group General Counsel Amsterdam, 16 June 2023 – VEON Ltd. (Nasdaq: VEON, Euronext Amsterdam: VEON), a global digital operator that provides converged connectivity and...
NRG Therapeutics Appoints Dr Jonathan Savidge as Independent Chair
April 26, 2023 04:00 ET
|
NRG Therapeutics Limited
STEVENAGE, United Kingdom, April 26, 2023 (GLOBE NEWSWIRE) -- NRG Therapeutics, Ltd., an innovative neuroscience company targeting mitochondrial dysfunction, is pleased to announce that it has...
NRG Therapeutics Appoints Vad Lazari Ph.D. as Vice President of Biology to Advance its Mitochondrial Therapeutics for Neurodegenerative Disorders
April 19, 2023 04:00 ET
|
NRG Therapeutics Limited
Vad Lazari Ph.D., appointed to the newly created position of VP of Biology, based in Stevenage, UKJoins from Charles River and brings two decades of drug discovery experience including at Pfizer and...
NRG Therapeutics Announces International Scientific Advisory Board
March 30, 2023 04:00 ET
|
NRG Therapeutics Limited
STEVENAGE, United Kingdom, March 30, 2023 (GLOBE NEWSWIRE) -- NRG Therapeutics, Ltd., an innovative neuroscience company targeting mitochondrial dysfunction, is pleased to announce the formation of...
MitoRx Therapeutics Announces Scientific Advisory Board, Chief Development Officer and Finance Director
March 07, 2023 03:00 ET
|
MitoRx Therapeutics
OXFORD, England, March 07, 2023 (GLOBE NEWSWIRE) -- MitoRx Therapeutics (MitoRx), a biotechnology company developing revolutionary therapeutics that reverse mitochondrial dysfunction to arrest the...
NRG Therapeutics Appoints Gilles Ouvry Ph.D. as Vice President of Chemistry to Advance its Mitochondrial Therapeutics for Neurodegenerative Disorders
February 09, 2023 04:01 ET
|
NRG Therapeutics Limited
Gilles Ouvry Ph.D, appointed to newly created position of VP of Chemistry, based in Stevenage, UKJoins from Evotec, UK and brings 20 years of international medicinal chemistry experience including at...